Nuvation Bio

NUVB • NYSE • Stock Fundamentals

Nuvation Bio is a biotechnology company in the healthcare sector trading on NYSE, led by CEO David T. Hung, with a market cap of $1.7B.

Market Cap$1.7B

Employees159.0

CEODavid T. Hung

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 4, 2026 · 1 month 10 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Nuvation Bio

Nuvation Bio (NUVB) has a market capitalization of $1.7B and trades on NYSE.

Nuvation Bio has approximately 159 employees.